Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies

News : Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

Research and Markets: Vaccine Market to 2019 - The Market is Expected to Reach $57.8 Billion by 2019 from $33.1 Billion in 2014

08/14/2015 | 10:50am EST

Research and Markets (http://www.researchandmarkets.com/research/mcbchq/vaccine_market_by) has announced the addition of the "Vaccine Market by Technology, Type, End User, Disease Indication - Forecasts to 2019" report to their offering.

Vaccine Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) - Forecasts to 2019

The vaccines market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%. For the purposes of this report the global vaccines market is categorized on the basis of type, technology, disease indication, end user, and geography. The preventive vaccines segment is expected to register the highest growth rate in the vaccines market, by type, during the forecast period. Its favorable growth is attributed to the rising prevalence of diseases and increasing number of government initiatives taken for immunization programs worldwide.

Major factors contributing to growth of the vaccines market include rising prevalence of diseases, increasing company investments in vaccine development, and rising initiatives by non-government organizations for vaccinations. Furthermore, government support in the form of funding is another major factor providing impetus for growth of this market. For instance, in November 2014, the U.K. government granted $2 billion (£1.32 billion) to GAVI for the improvement of immunization programs in poor countries.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Vaccines Market, By Technology

8 Vaccines Market, By Type

9 Vaccines Market, By Disease Indication

10 Vaccines Market, By End User

11 Global Vaccine Technology Market, By Region

12 Competitive Landscape

13 Company Profiles

14 Appendix

Companies Mentioned

  • Bavarian Nordic
  • CSL Limited
  • Emergent Biosolutions, Inc.
  • Glaxosmithkline, PLC.
  • Johnson & Johnson
  • Medimmune, LLC. (A Subsidiary of Astrazeneca)
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.
  • SANOFI

For more information visit http://www.researchandmarkets.com/research/mcbchq/vaccine_market_by


© Business Wire 2015
Latest news "Companies"
05:59pCHINA REINSURANCE  : Proxy form of holders of h shares for the first extraordinary general meeting of 2021 to be held on 20 april 2021
PU
05:59pBANCO SANTANDER BRASIL S A  : 03/01/2021 - Composition of the Company's Sustainability Committee
PU
05:58pINTEL  : AI chip firm Wave Computing emerges from Chapter 11 bankruptcy protection
RE
05:58pMAXIM POWER CORP.  : Announces the Receipt of the Second Line Loss Proceedings Payment
AQ
05:57pUNITI : 4Q Earnings Snapshot
AQ
05:57pIMF Executive Board Approves a 36-month US.778 Billion Extended Arrangement under the Extended Fund Facility for Costa Rica and Concludes 2021 Article IV Consultation HTML File
PU
05:56pKen Kladouris Celebrates 10 Year Anniversary in the Wealth Management Industry
PR
05:56pMore Than $1.5 Million in Micro-Grants Aids Colorado Governments
BU
05:55pNike's North American head steps down after report reveals ties to resale business
RE
05:55pSINOPHARM  : Venezuela approves use of China's Sinopharm coronavirus vaccine
RE
Latest news "Companies"